Dextech Medical AB

Not Rated
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0005881489
SEK
8.40
0.9 (12.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Dextech Medical AB Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Jun'24
Jun'23
Jun'22
Jun'21
Jun'20
Jun'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-4.00
-4.00
-5.00
-6.00
-7.00
-8.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
0.00
-1.00
-2.00
-1.00
-2.00
-1.00
Cash Flow from Investing Activities
-5.00
-8.00
-3.00
0.00
0.00
-2.00
Cash Flow from Financing Activities
0.00
0.00
37.00
0.00
8.00
0.00
Net Cash Inflow / Outflow
-6.00
-10.00
32.00
-2.00
6.00
-3.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in SEK Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Dextech Medical AB
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Profit Before Tax
-4.705567
-41.959818
37.00
88.79%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
0.20939
3.206768
-3.00
-93.47%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-0.807616
-37.778383
37.00
97.86%
Cash Flow from Investing Activities
-5.385186
-0.083509
-5.00
-6348.63%
Cash Flow from Financing Activities
0
34.627344
-34.00
-100.00%
Net Cash Inflow / Outflow
-6.192802
-3.234548
-3.00
-91.46%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Jun'24
stock-summary

YoY Growth in year ended Jun 2024 is 47.97% vs 22.39% in Jun 2023

Jun'24
Jun'23
Change(%)
Cash Flow from Operating Activities
-0.81
-1.55
47.97%